Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)

A Yilmaz, J Bauersachs, F Bengel, R Büchel… - Clinical Research in …, 2021 - Springer
Systemic forms of amyloidosis affecting the heart are mostly light-chain (AL) and
transthyretin (ATTR) amyloidoses. The latter is caused by deposition of misfolded …

[HTML][HTML] An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease

DP Germain, G Altarescu, R Barriales-Villa… - Molecular genetics and …, 2022 - Elsevier
Fabry disease is an X-linked inherited lysosomal disorder that causes accumulation of
glycosphingolipids in body fluids and tissues, leading to progressive organ damage and …

An IoT-based computational framework for healthcare monitoring in mobile environments

H Mora, D Gil, R Munoz Terol, J Azorín, J Szymanski - Sensors, 2017 - mdpi.com
The new Internet of Things paradigm allows for small devices with sensing, processing and
communication capabilities to be designed, which enable the development of sensors …

Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown …

BE Smid, L Van Der Tol, F Cecchi, PM Elliott… - International journal of …, 2014 - Elsevier
Background Screening in subjects with left ventricular hypertrophy (LVH) reveals a high
prevalence of Fabry disease (FD). Often, a diagnosis is uncertain because characteristic …

The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage

JB Augusto, N Johner, D Shah, S Nordin… - European Heart …, 2021 - academic.oup.com
Abstract Aims Cardiac involvement in Fabry disease (FD) occurs prior to left ventricular
hypertrophy (LVH) and is characterized by low myocardial native T1 with sphingolipid …

[HTML][HTML] Electrocardiographic features and rhythm disorders in cardiac amyloidosis

N Martini, G Sinigiani, L De Michieli… - Trends in …, 2023 - Elsevier
Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy caused by extracellular
deposition of amyloid fibrils, mainly derived from transthyretin, either wild-type or hereditary …

[HTML][HTML] Electrocardiographic changes and arrhythmia in Fabry disease

M Namdar - Frontiers in Cardiovascular Medicine, 2016 - frontiersin.org
Fabry disease is an X-chromosome-linked lysosomal storage disease characterized by a
deficient activity or, in most males, absence of the enzyme α-galactosidase A (a-Gal A) …

Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques

WA AlJaroudi, MY Desai, WHW Tang, D Phelan… - Journal of Nuclear …, 2014 - Elsevier
Amyloidosis is an infiltrative disease characterized by deposition of amyloid fibrils within the
extracellular tissue of one or multiple organs. Involvement of the heart, cardiac amyloidosis …

Invasive and non-invasive diagnostic pathways in the diagnosis of cardiac amyloidosis

A Briasoulis, D Bampatsias, A Papamichail… - Journal of …, 2023 - mdpi.com
The appropriate diagnosis and subtyping of cardiac amyloidosis (CA) is frequently missed or
delayed due to its vague presentation, clinical overlapping, and diagnostic pitfalls. Recent …

[HTML][HTML] Restrictive cardiomyopathies: the importance of noninvasive cardiac imaging modalities in diagnosis and treatment—a systematic review

A Rammos, V Meladinis, G Vovas… - Radiology research and …, 2017 - hindawi.com
Restrictive cardiomyopathy (RCM) is the least common among cardiomyopathies. It can be
idiopathic, familial, or secondary to systematic disorders. Marked increase in left and/or right …